Tianjin Ringpu Bio-Technology Co.,Ltd. (300119.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap8.53B
Enterprise Value9.03B
P/E Ratio21.93
PEG Ratio-1.73
Price/Sales Ratio2.28
Price/Book Ratio1.62
Enterprise/Revenue2.66
Enterprise/EBITDA15.1

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.1
Operating Margin0.12
AD

Management Effectiveness

Return On Assets0.04
Return On Equity0.07

Income Statement

Revenue3.4B
Revenue/Share7.51
Gross Profit1.4B
EBITDA729.46M
Net Income400.51M
Diluted EPS0.88

Balance Sheet

Total Cash1.55B
Total Cash/Share3.42
Total Debt1.82B
Total Debt/Equity0.39
Current Ratio1.62
Book Value Per Share11.28

Price History

52-Week Change-20.94
52-Week High22.96
52-Week Low13.91
Moving Average 50 Days17.46
Moving Average 200 Days17.84

Statistics

Average Volume5.69M
Shares Outstanding464.75M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.4
Trailing Annual Dividend Yield2.39
Payout Ratio0.97
Last Split Factor1993579:1000000
Last Split DateApril 22, 2014
AD